Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients?

Transplantation

Volumn 90, Issue 7, 2010, Pages 791-798

  Fedrigo, Marny ^a   Gambino, Antonio ^b   Tona, Francesco ^b   Torregrossa, Gianluca ^b   Poli, Francesca ^c   Benazzi, Elena ^c   Frigo, Annachiara ^b   Feltrin, Giuseppe ^b   Toscano, Giuseppe ^b   Caforio, Alida P ^b   Iliceto, Sabino ^b   Valente, Marialuisa ^a   Thiene, Gaetano ^a   Gerosa, Gino ^b   Angelini, Annalisa ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c IRCCS   (Italy)

Author keywords

AMR; C4d complement deposition; CAV; Endomyocardial biopsy; Immunohistochemistry; Transplant

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C4D;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY; BLOOD GROUP INCOMPATIBILITY; CAPILLARIES; COMPLEMENT C4B; EDEMA; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PEPTIDE FRAGMENTS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 77958017387     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181efd059     Document Type: Article

References (52)

1. Hammond EH, Yowell RL, Nunoda S, et al. Vascular (humoral) rejection in heart transplantation: Pathologic observations and clinical implications. J Heart Transplant 1989; 8: 430.
2. Baldwin WM III, Samaniego-Picota M, Kasper EK, et al. Complement deposition in early cardiac transplant biopsies is associated with isch-emic injury and subsequent rejection episodes. Transplantation 1999; 68: 894.
3. Lones MA, Czer LS, Trento A, et al. Clinical-pathologic features of Humoral Rejection in cardiac allografts: A study in 81 consecutive patients. J Heart Lung Transplant 1995; 14: 151.
4. Tan CD, Baldwin WM III, Rodriguez ER. Updateoncardiac transplantation pathology. Arch Pathol Lab Med 2007; 131: 1169.
5. Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208.
6. Platt JL. C4d and the fate oforgan allografts. J Am Soc Nephrol 2002; 13: 2417.
7. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333.
8. Crespo M, Pascual M, Tolkoff-Rubin N, et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652.
9. Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: New concepts in diagnosis and treatment. Curr Opin Nephrol Hyper-tens 2002; 11: 609.
10. Nickeleit V, Zeiler M, Gudat F, et al. Detection of the complement degradation product c4d inrenal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242.
11. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779.
12. Crespo-Leiro M, Veiga-Barreiro A, Paniagua DMJ, et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): Incidence, management and the value of C4d for diagnosis. Am J Transplant 2005; 5: 2560.
13. Fedson SE, Daniel SS, Husain AN, et al. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplant. J Heart Lung Transplant 2008; 27: 372.
14. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.
15. Williams JM, Holzknecht ZE, Plummer TB, et al. Acute vascular rejection and accommodation: Divergent outcomes of the humoral response to organ transplantation. Transplantation 2004; 78: 1471.
16. Fiebeler A, Mengel M, Merkel S, et al. Diffuse C4d deposition and morphology of acute humoral rejection in a stable renal allograft. Transplantation 2003; 76: 1132.
17. Tan CD, Sokos GG, Pidwell DJ, et al. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antbibody-mediated rejection. Am J Transplant 2009; 9: 2075.
18. Koch CA, Khalpey ZI, Platt JL. Accommodation: Preventing injury in transplantation and disease. J Immunol 2004; 172: 5143.
19. Baldwin WM III, Kasper EK, Zachary AA, et al. Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant 2004; 4: 311.
20. Tang AH, Platt JL. Accommodation of grafts: Implications for health and diseases. Hum Immunol 2007; 68: 645.
21. Wu GW, Kobashigawa JA, Fishbein MC, et al Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009; 28: 417.
22. Stork S, Bher TM, Birk M, et al. Assessment of cardiac allograft vascu-lopathy late after heart transplantation: When is coronary angiography necessary? J Heart Lung Transplant 2006; 25: 1103.
23. De Gouveia RH, Vitorino E, Ramos S, et al. C4d-the witness of humoral rejection. Transplant Proc 2009; 41: 866.
24. Behr TM, Feucht HE, Richter K, et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999; 18: 904.
25. Rordiguez ER, Skojec DV, Tan CD, et al. Antibody-mediated rejection in human cardiac allograft: Evaluation of immunoglobulins and complement activation products C4d and C3d markers. Am J Transplant 2004; 5: 2778.
26. Bohming GA, Bartel G, Regele H, et al. Prospects and limitations of post-transplantation alloantibody detection in renal transplantation. Hum Immunol 2009; 70: 640.
27. Angelini A, Castellani C, Poli F, et al. Antibody mediated rejection without acute graft dysfunction in adult ABO compatible heart transplantation: A case of accommodation. J Heart Lung Transplant 2008; 27: 1357.
28. Colvin RB, Smith N. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807.
29. Takemoto SK, Zeevi A, Feng S, et al. National conference to asses antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033.
30. Michaels PJ, Fishbein MC, Colvin RB. Humoral rejection of human organ transplants. Springer Semin Immunopathol 2003; 25: 119.
31. Cesarez TW, Perens G, William RJ, et al. Humoral rejection in pediatric orthotopic heart transplantation. J heart Lung Transplant 2007; 26: 114.
32. Baldwin WM, Ota H, Rodriguez ER. Complement in transplant rejection: Diagnostic and mechanistic considerations. Springer Semin Immunopathol 2003; 5: 181.
33. Gonzalez-Stawinski GV, Tan CD, Smedira NG, et al. Decay-accelerating factor expression may provide immunoprotection against antibody-mediated cardiac allograft rejection. J Heart Lung Transplant 2008; 27:357.
34. Dalmasso AP, Benson BA, Johnson JS, et al,. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gala(1-3)Gal binding lectin: Up-regulation of CD59 expression. J Immunol 2000; 3: 54.
35. Kfoury A, Stehlik J, Renlund DG, et al. Impact of Repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: Defining rejection patterns. J Heart Lung Transplant 2006; 25: 1277.
36. Hammond EH, Yowell RL, Prince GD, et al. Vascular rejection and its relationship to allograft coronary artery disease. J heart Lung Transplant 1992; 11: S111.
37. Kfoury AG, Renlund DG, Snow GL, et al. Aclinical correlation study of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant 2009; 28: 51.
38. Kfoury AG, Hammond ME, Snow GL, et al. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart LungTransplant 2009; 28: 781.
39. Poelzl G, Ullrich R, Huber A, et al. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allo-graft vasculopathy. Transpl Int 2005; 18: 313.
40. Michaels PJ, Espejo ML, Kobashigawa J, et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22: 58.
41. Wehner J, Morrell CN, Reynolds T, et al. Antibody and complement in transplant vasculopathy. Circ Res 2007; 100: 191.
42. Qian Z, Hu W, Liu J, et al. Accelerated graft atherosclerosis in cardiac transplants: Complement activation promotes progressionoflesions in from medium to large arteries. Transplantation 2001; 72: 900.
43. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
44. Caforio ALP, Tona F, Fortina AB, et al. Immune and non immune predictors of cardiac allograft vasculopahty onset and severity: Multi-variate risk factor analysis and role of immunosuppression. Am J Transplant 2004; 4: 962.
45. Billingham ME, Cary NRB, Hammond EH, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990; 9: 587.
46. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25: 153.
47. Hammond ME, Stehlik J, Snow G, et al. Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: A study of 3,170 biopsies. J Heart Lung Transplant 2005; 24: 2015.
48. Bohmig GA, Exner M, Habicht A, et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091.
49. Chantranuwat C, Qiao JH, Kobashigawa J, et al. Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft en-domyocardial biopsies: Comparison to frozen tissue immunofluores-cence. Appl Immunohistochem Mol Morphol 2004; 12: 166.
50. Colombo MB, Haworth SE, Poli F, et al. Luminex technology for anti-HLA antibody screening: Evaluation of performance and of impact on laboratory routine. Cytometry B Clin Cytom 2007; 72: 465.
51. Mizutani K, Terasaki P, Hamdani E, et al. The importance of anti-HLA specific antibody strength in monitoring kidney transplant patients. Am J Transplant 2007; 7: 1027.
52. Gao SZ, Alderman EL, Schoeder JS, et al Accelerated coronary vascular disease in the heart transplant patients: Coronary arteriographic findings. J Am Coll Cardiol 1988; 12: 334.